Angle plc, a liquid biopsy company, has secured a valuable partnership with molecular testing giant Qiagen and an exclusive option agreement with Queen Mary University of London. Angle is known for Parsortix, its novel system for capturing and harvesting circulating tumor cells (CTCs) from blood.
{iframe}https://www.mddionline.com/qiagen-partners-cell-diagnostics-company{/iframe}